Anika Therapeutics, Inc. (ANIK) Executive Compensation
Anika Therapeutics, Inc. (ANIK) is a publicly traded company on the Nasdaq, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ANIK
CIK: 898437
Exchange: Nasdaq
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerCasey Griffin
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 144 | 2026-08-07 | — | 144 Filing | 0001959173-26-005793 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 | 0001193125-26-335269 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-31 | — | SCHEDULE 13G/A Filing | 0002100119-26-001342 | View SEC Doc Filr Page |
| S-8 | 2026-07-29 | — | FORM S-8 | 0001171843-26-005017 | View SEC Doc Filr Page |
| 10-Q | 2026-07-29 | 2026-06-30 | FORM 10-Q | 0001171843-26-005012 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-29 | FORM 8-K | 0001171843-26-004977 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-17 | — | SCHEDULE 13G/A Filing | 0002052113-26-000740 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-10 | FORM 8-K | 0001171843-26-004635 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | 4 | 0001193125-26-279545 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | 4 | 0001193125-26-279542 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | 4 | 0001193125-26-279541 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | 4 | 0001193125-26-279539 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | 4 | 0001193125-26-279535 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-18 | FORM 8-K | 0001171843-26-004253 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-08 | — | DEFA14A | 0001140361-26-024374 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 | 0001193125-26-259520 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-01 | — | DEFA14A | 0001140361-26-023475 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-01 | 4 | 0001193125-26-202704 | View SEC Doc Filr Page |
| 4 | 2026-04-30 | 2026-04-30 | 4 | 0001193125-26-197887 | View SEC Doc Filr Page |
| 10-Q | 2026-04-30 | 2026-03-31 | FORM 10-Q | 0001171843-26-002852 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-29 | — | SCHEDULE 13G Filing | 0002100119-26-000113 | View SEC Doc Filr Page |
| 8-K | 2026-04-29 | 2026-04-24 | FORM 8-K | 0001171843-26-002799 | View SEC Doc Filr Page |
| ARS | 2026-04-28 | 2025-12-31 | ARS | 0001140361-26-017490 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-28 | — | DEFA14A | 0001140361-26-017489 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-28 | 2026-06-18 | DEF 14A | 0001140361-26-017488 | View SEC Doc Filr Page |